August 24, 2017 3:47 AM ET

Life Sciences Tools and Services

Company Overview of Progenitor Cell Therapy, LLC

Company Overview

Progenitor Cell Therapy, LLC provides contract development and manufacturing services for cell therapy products. The company offers manufacturing solutions; engineering and innovation services; product and process development services; cell and tissue processing; storage, distribution, and delivery of tissues, primary cells, and cell therapy products; and consulting and regulatory support services, such as product and process development, GTP/cGMP manufacturing, regulatory services, and business development and commercialization. It serves academic, biotech, pharmaceutical, and professional clients in the United States. The company was founded in 1997 and is based in Allendale, New Jersey. I...

4 Pearl Court

Suite C

Allendale, NJ 07401

United States

Founded in 1997

Phone:

201-883-5300

Fax:

201-883-1409

Key Executives for Progenitor Cell Therapy, LLC

President, Chief Scientific Officer and Member of Board Manager
Age: 60
Chief Medical Officer
Age: 59
Senior Vice President of Investor Relations
Director of Human Resources
Vice President of Business Development
Compensation as of Fiscal Year 2017.

Progenitor Cell Therapy, LLC Key Developments

PCT Presents at The Cell & Gene Meeting on the Mesa, Oct-05-2016 through Oct-07-2016

PCT Presents at The Cell & Gene Meeting on the Mesa, Oct-05-2016 through Oct-07-2016. Venue: La Jolla, CA 92037, United States. Presentation Date & Speakers: Oct-05-2016, Robert Preti, Ph.D, President, Robert Preti, Ph.D., President. Oct-06-2016, Robert Preti, Ph.D., President, Robert Preti, President.

PCT, LLC to Expand its Current Manufacturing Capacity at Allendale, New Jersey Facility to Support IRX Therapeutics

PCT, LLC announced that it will expand its current manufacturing capacity at PCT's Allendale, New Jersey facility to support IRX Therapeutics Inc.'s anticipated clinical trial manufacturing needs for the INSPIRE Phase 2b study in head and neck cancer patients. PCT will provide IRX with personnel and dedicated clean room capacity within its current Good Manufacturing Practices (cGMP) infrastructure and, subsequently, pursuant to European Union (EU) cell therapy manufacturing standards. The expanded arrangement includes IRX's use of PCT's ISO Class 6/Class 1,000 clean room system, enabling manufacture of cell-based products that can then be shipped to Europe and, when approved, commercially distributed on the EU market.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Progenitor Cell Therapy, LLC, please visit pctcelltherapy.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.